Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02344407
What this trial is testing

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Not applicableStudy completedNCT02933931
What this trial is testing

Immune Durability After VSV-EBOV Vaccination

Who this might be right for
Immune ResponseVaccinationDurability
University Hospital, Geneva 95
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Early research (Phase 1)Study completedNCT02314923
What this trial is testing

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 513
Early research (Phase 1)Study completedNCT02376400
What this trial is testing

Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 78
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Testing effectiveness (Phase 2)Study completedNCT02416453
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

Who this might be right for
Ebola Viral Disease
Janssen Vaccines & Prevention B.V. 423
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Early research (Phase 1)Study completedNCT02376426
What this trial is testing

Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 72
Early research (Phase 1)Ended earlyNCT03462004
What this trial is testing

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT02269423
What this trial is testing

Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT02240875
What this trial is testing

Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Who this might be right for
EbolaEbola Zaire
University of Oxford 91
Not applicableStudy completedNCT03140774
What this trial is testing

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Who this might be right for
Ebola Virus Disease
University of Oxford 126
Testing effectiveness (Phase 2)Study completedNCT02287480
What this trial is testing

VSV-ZEBOV Geneva Vaccine Trial

Who this might be right for
Ebolavirus Disease
University Hospital, Geneva 115
Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Early research (Phase 1)UnknownNCT02296983
What this trial is testing

Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Next Page